BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30423626)

  • 1. [Diagnostic value of serum cardiac biomarkers for right ventricular dysfunction in non-high-risk patients with acute pulmonary thromboembolism].
    Liu FF; Gong JN; Jiang Y; Kuang TG; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):847-852. PubMed ID: 30423626
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid on-site evaluation of routine biochemical parameters to predict right ventricular dysfunction in and the prognosis of patients with acute pulmonary embolism upon admission to the emergency room.
    Jia D; Liu F; Zhang Q; Zeng GQ; Li XL; Hou G
    J Clin Lab Anal; 2018 May; 32(4):e22362. PubMed ID: 29160572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography.
    Granér M; Harjola VP; Selander T; Laiho MK; Piilonen A; Raade M; Mustonen P
    Heart Lung Circ; 2016 Jun; 25(6):592-9. PubMed ID: 26809463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism.
    Ozsu S; Karaman K; Mentese A; Ozsu A; Karahan SC; Durmus I; Oztuna F; Kosucu P; Bulbul Y; Ozlu T
    Thromb Res; 2010 Dec; 126(6):486-92. PubMed ID: 20920821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism.
    Choi HS; Kim KH; Yoon HJ; Hong YJ; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC; Kang JC
    J Cardiol; 2012 Dec; 60(6):508-13. PubMed ID: 22902901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction.
    Henzler T; Roeger S; Meyer M; Schoepf UJ; Nance JW; Haghi D; Kaminski WE; Neumaier M; Schoenberg SO; Fink C
    Eur Respir J; 2012 Apr; 39(4):919-26. PubMed ID: 21965223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].
    Yang C; Liu F; Han M; Li B; Shen Q; Xu P; Yang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):711-715. PubMed ID: 32684218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helical computerized tomography and NT-proBNP for screening of right ventricular overload on admission and at long term follow-up of acute pulmonary embolism.
    Laiho MK; Harjola VP; Graner M; Piilonen A; Raade M; Mustonen P
    Scand J Trauma Resusc Emerg Med; 2012 May; 20():33. PubMed ID: 22559861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.
    Ates H; Ates I; Kundi H; Yilmaz FM
    Herz; 2017 Dec; 42(8):758-765. PubMed ID: 27966013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of PESI, echocardiogram, CTPA, and NT-proBNP as risk stratification tools in patients with acute pulmonary embolism.
    Vamsidhar A; Rajasekhar D; Vanajakshamma V; Lakshmi AY; Latheef K; Siva Sankara C; Obul Reddy G
    Indian Heart J; 2017; 69(1):68-74. PubMed ID: 28228310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.
    Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Kuhnert K; Hasenfuß G; Pruszczyk P; Konstantinides S
    Eur Respir J; 2014 Jun; 43(6):1669-77. PubMed ID: 24627529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent NT-proBNP elevation in acute pulmonary embolism predicts early death.
    Kostrubiec M; Pruszczyk P; Kaczynska A; Kucher N
    Clin Chim Acta; 2007 Jul; 382(1-2):124-8. PubMed ID: 17507005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart-type fatty acid binding protein for the assessment of the short-term prognosis in acute pulmonary embolism patients with hemodynamic stability on admission].
    Chen Y; Liu S; Guo W; Wang ZZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):516-21. PubMed ID: 24262088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein in acute pulmonary embolism.
    Abul Y; Karakurt S; Ozben B; Toprak A; Celikel T
    J Investig Med; 2011 Jan; 59(1):8-14. PubMed ID: 21218608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism.
    Vuilleumier N; Righini M; Perrier A; Rosset A; Turck N; Sanchez JC; Bounameaux H; Le Gal G; Mensi N; Hochstrasser D
    Thromb Res; 2008; 121(5):617-24. PubMed ID: 17716710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of computed tomographic pulmonary angiography in the risk stratification of acute pulmonary thromboembolism. Comparison with cardiac biomarkers.
    Seon HJ; Kim KH; Lee WS; Choi S; Yoon HJ; Ahn Y; Kim YH; Jeong MH; Cho JG; Park JC; Kang JC
    Circ J; 2011; 75(2):428-36. PubMed ID: 21173497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of CT for detection of right ventricular dysfunction in acute pulmonary embolism, and comparison with cardiac biomarkers.
    İn E; Aydın AM; Özdemir C; Sökücü SN; Dağlı MN
    Jpn J Radiol; 2015 Aug; 33(8):471-8. PubMed ID: 26118888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
    Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
    Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis.
    Cappelli F; Baldasseroni S; Bergesio F; Padeletti L; Attanà P; Pignone AM; Grifoni E; Ciuti G; Fabbri A; Tarantini F; Marchionni N; Gensini GF; Perfetto F
    Amyloid; 2014 Jun; 21(2):97-102. PubMed ID: 24517408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker-based risk assessment model in acute pulmonary embolism.
    Kostrubiec M; Pruszczyk P; Bochowicz A; Pacho R; Szulc M; Kaczynska A; Styczynski G; Kuch-Wocial A; Abramczyk P; Bartoszewicz Z; Berent H; Kuczynska K
    Eur Heart J; 2005 Oct; 26(20):2166-72. PubMed ID: 15911566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.